TABLE 2.
Multivariable analysis of factors associated with retention, antiretroviral therapy (ART) use, and virologic suppression in a cohort of HIV-positive patients from Buenos Aires, Argentina, 2011–2014a
| Characteristic | Retentionb
|
ART usec
|
Virologic suppressiond
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted ORe (95% CIf) |
P |
Adjusted OR (95% CI) |
P | Unadjusted OR (95% CI) |
P | Adjusted OR (95% CI) |
P | Unadjusted OR (95% CI) |
P | Adjusted OR (95% CI) |
P | |
| Age (years) | 0.006 | 0.016 | 0.570 | 0.303 | 0.368 | 0.822 | ||||||
| < 35 | 0.67 (0.50–0.89) |
0.64 (0.44–0.92) |
0.88 (0.58–1.35) |
1.359 (0.76–2.44) |
0.80 (0.50–1.29) |
0.94 (0.54–1.64) |
||||||
| ≥ 35 | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
| Gender | 0.161 | 0.640 | 0.326 | 0.030 | 0.543 | 0.670 | ||||||
| Male | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
| Female | 1.28 (0.91–1.81) |
1.11 (0.72–1.69) |
0.79 (0.49–1.27) |
0.49 (0.26–0.93) |
0.85 (0.49–1.46) |
0.87 (0.46–1.66) |
||||||
| Residence | 0.498 | 0.009 | 0.014 | 0.092 | 0.603 | 0.802 | ||||||
| City of Buenos Aires | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
| Other | 0.91 (0.68–1.21) |
0.62 (0.43–0.89) |
1.74 (1.12–2.71) |
1.66 (0.92–2.98) |
1.14 (0.70–1.84) |
1.07 (0.62–1.85) |
||||||
| CD4 count (cells/μL) | 0.035 | 0.068 | <0.001 | <0.001 | 0.035 | 0.023 | ||||||
| < 200 | 1.73 (1.12–2.66) |
1.65 (1.05–2.60) |
35.72 (10.84–117.67) |
39.04 (11.60–131–38) |
2.07 (1.06–4.04) |
2.17 (1.07–4.38) |
||||||
| 200–499 | 1.44 (0.97–2.15) |
1.45 (0.96–2.18) |
7.13 (3.85–13.20) |
7.46 (3.95–14.10) |
2.24 (1.17–4.30) |
2.46 (1.26–4.81) |
||||||
| ≥ 500 | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
a
Adjusted models include all terms in table.
b
Retention indicator: individuals with at least one visit (clinic or laboratory (CD4 or viral load (VL)) or pharmacy pickup) during 2014.
c
ART use indicator: prescription of ART for at least 90 days or at least three notations of ART pickup from the pharmacy in 2014 among those retained.
d
Virologic suppression indicator: viral load (VL)< 200 copies/ml at last measurement in 2014 among those with at least one VL performed in 2014.
e
OR = odds ratio.
f
CI = confidence interval.